[Effect of interleukin 15 on the PMN activity in Lyme borreliosis]

Ewa Jabłońska1, Magdalena Marcińczyk, Aneta Izycka

  • 1Zakład Immunologii Akademii Medycznej w Białymstoku.

Insights

Interleukin-15 (IL-15) enhances neutrophil activity in Lyme disease patients. This study found increased neutrophil locomotion, phagocytosis, and NBT reduction following IL-15 stimulation, suggesting a modulatory role in the disease.

Area of Science:

  • Immunology
  • Infectious Diseases

Context:

  • Lyme disease is a tick-borne illness caused by Borrelia burgdorferi.
  • Neutrophils play a critical role in the innate immune response to bacterial infections.
  • Dysregulation of immune cell function may contribute to Lyme disease pathogenesis.

Purpose:

  • To investigate the effect of recombinant human interleukin-15 (rhIL-15) on neutrophil (PMN) functions in patients with Lyme disease.
  • To assess changes in PMN locomotion, phagocytosis, and nitroblue tetrazolium (NBT) reduction upon IL-15 stimulation.
  • To determine IL-15 serum levels in Lyme disease patients compared to controls.

Summary:

  • Neutrophil activity, including locomotion, phagocytosis, and NBT reduction, was significantly increased after rhIL-15 stimulation in Lyme disease patients.
  • Serum samples from Lyme disease patients exhibited elevated levels of IL-15 compared to healthy controls.
  • These findings indicate that IL-15 modulates neutrophil function during active Lyme disease.

Impact:

  • IL-15 may represent a therapeutic target for modulating immune responses in Lyme disease.
  • Understanding IL-15's role in neutrophil function can provide insights into Lyme disease immunopathogenesis.
  • This research highlights the complex interplay between cytokines and innate immunity in chronic infections.

Related Concept Videos